Analyses of Valtoco (diazepam nasal spray) to be presented at Child Neurology Society meeting – Neurelis
Neurelis, Inc., announced additional findings from the post hoc analysis of the long-term phase III safety study of Valtoco (diazepam nasal spray) in a pediatric population, aged 6-17… read more.
